Home › Compare › DLTNF vs JNJ

DLTNF vs JNJ: Dividend Comparison 2026

DLTNF yields 26490.07% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DLTNF wins by $856500661636595056640.00M in total portfolio value
10 years
DLTNF
DLTNF
● Live price
26490.07%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$856500661636595056640.00M
Annual income
$850,187,174,759,804,400,000,000,000.00
Full DLTNF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DLTNF vs JNJ

📍 DLTNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDLTNFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DLTNF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DLTNF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DLTNF
Annual income on $10K today (after 15% tax)
$2,251,655.63/yr
After 10yr DRIP, annual income (after tax)
$722,659,098,545,833,800,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DLTNF beats the other by $722,659,098,545,833,800,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DLTNF + JNJ for your $10,000?

DLTNF: 50%JNJ: 50%
100% JNJ50/50100% DLTNF
Portfolio after 10yr
$428250330818297528320.00M
Annual income
$425,093,587,379,902,200,000,000,000.00/yr
Blended yield
99.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DLTNF
No analyst data
Altman Z
-1.9
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DLTNF buys
0
JNJ buys
0
No recent congressional trades found for DLTNF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDLTNFJNJ
Forward yield26490.07% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$856500661636595056640.00M ✓$20.0K
Annual income after 10y$850,187,174,759,804,400,000,000,000.00 ✓$827.78
Total dividends collected$856084953147245199360.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DLTNF vs JNJ ($10,000, DRIP)

YearDLTNF PortfolioDLTNF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,659,707$2,649,006.62$10,676$355.77+$2.65M → DLTNF
2$661,311,349$658,465,463.27$11,407$389.39+$661.30M → DLTNF
3$153,718,184,329$153,010,581,185.41$12,198$426.53+$153718.17M → DLTNF
4$33,404,167,863,182$33,239,689,405,949.67$13,056$467.62+$33404167.85M → DLTNF
5$6,786,439,075,574,744$6,750,696,615,961,140.00$13,987$513.12+$6786439075.56M → DLTNF
6$1,289,019,706,709,597,000$1,281,758,216,898,732,000.00$14,998$563.56+$1289019706709.58M → DLTNF
7$228,909,915,433,776,940,000$227,530,664,347,597,670,000.00$16,098$619.52+$228909915433776.94M → DLTNF
8$38,007,474,205,860,660,000,000$37,762,540,596,346,516,000,000.00$17,295$681.69+$38007474205860656.00M → DLTNF
9$5,900,455,025,037,820,000,000,000$5,859,787,027,637,549,000,000,000.00$18,599$750.82+$5900455025037819904.00M → DLTNF
10$856,500,661,636,595,100,000,000,000$850,187,174,759,804,400,000,000,000.00$20,022$827.78+$856500661636595056640.00M → DLTNF

DLTNF vs JNJ: Complete Analysis 2026

DLTNF — Stock

Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, decontamination pods, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. As of April 20, 2022, the company owned and operated 35 retail stores under the Delta 9 brand name across the Canadian Prairies. Delta 9 Cannabis Inc. was incorporated in 2001 and is headquartered in Winnipeg, Canada.

Full DLTNF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DLTNF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DLTNF vs SCHDDLTNF vs JEPIDLTNF vs ODLTNF vs KODLTNF vs MAINDLTNF vs ABBVDLTNF vs MRKDLTNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.